Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 7-chloro-7-deoxylincomycin Palmitate
2. 7-chlorolincomycin Palmitate
3. Cleocin Palmitate
4. Clindamycin Palmitate
1. Clindamycin Palmitate Hcl
2. 25507-04-4
3. Cleocin Pediatric
4. Clindamycin 2-palmitate Hydrochloride
5. Vn9a8jm7m7
6. U-25,179 E
7. 25507-04-4 (palmitate Hcl)
8. Nsc-759141
9. U-25179e
10. U-25179-e
11. Clindamycin Palmitate (hydrochloride)
12. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yl Palmitate
13. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yl Palmitate Hydrochloride
14. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] Hexadecanoate;hydrochloride
15. Unii-vn9a8jm7m7
16. Ncgc00185773-02
17. U 25179e
18. Cleocin Pediatric (tn)
19. Dsstox_cid_28660
20. Dsstox_rid_82930
21. Dsstox_gsid_48734
22. Schembl41416
23. Clindamycin Palmitate Hydrochloride [usan:usp:jan]
24. Chembl1200632
25. Dtxsid3048734
26. Niosh/gf2450000
27. Chebi:34647
28. Hy-b1454
29. Tox21_113175
30. Mfcd09752824
31. Akos030242182
32. Ccg-270385
33. Nsc 759141
34. As-58470
35. Clindamycin-2-palmitate, Monohydrochloride
36. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside 2-palmitate Monohydrochloride
37. Cas-25507-04-4
38. Cs-0013162
39. Gf24500000
40. Clindamycin Palmitate Hydrochloride (jan/usp)
41. D01990
42. F20748
43. Clindamycin Palmitate Hydrochloride [jan]
44. Clindamycin Palmitate Hydrochloride [mart.]
45. Clindamycin Palmitate Hydrochloride [usan]
46. Clindamycin Palmitate Hydrochloride [vandf]
47. Clindamycin Palmitate Hydrochloride [usp-rs]
48. Clindamycin Palmitate Hydrochloride [who-dd]
49. J-016026
50. Q27291919
51. Clindamycin Palmitate Hydrochloride [orange Book]
52. Clindamycin Palmitate Hydrochloride [usp Monograph]
53. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, Monohydrochloride, (2s-trans)-
54. L-threo-alpha-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, Monohydrochloride, (2s-trans)-
55. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-palmitate Monohydrochloride
Molecular Weight | 699.9 g/mol |
---|---|
Molecular Formula | C34H64Cl2N2O6S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 23 |
Exact Mass | 698.3862143 g/mol |
Monoisotopic Mass | 698.3862143 g/mol |
Topological Polar Surface Area | 134 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 810 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Clindamycin palmitate hydrochloride |
Drug Label | Clindamycin palmitate hydrochloride is a water soluble hydrochloride salt of the ester of clindamycin and palmitic acid. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compoun... |
Active Ingredient | Clindamycin palmitate hydrochloride |
Dosage Form | For solution |
Route | Oral |
Strength | eq 75mg base/5ml |
Market Status | Prescription |
Company | Lyne; Amneal Pharms; Paddock Labs; Aurobindo Pharma |
2 of 2 | |
---|---|
Drug Name | Clindamycin palmitate hydrochloride |
Drug Label | Clindamycin palmitate hydrochloride is a water soluble hydrochloride salt of the ester of clindamycin and palmitic acid. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compoun... |
Active Ingredient | Clindamycin palmitate hydrochloride |
Dosage Form | For solution |
Route | Oral |
Strength | eq 75mg base/5ml |
Market Status | Prescription |
Company | Lyne; Amneal Pharms; Paddock Labs; Aurobindo Pharma |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?